- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 213/643 - 2-PhenoxypyridinesDerivatives thereof
Patent holdings for IPC class C07D 213/643
Total number of patents in this class: 176
10-year publication summary
|
7
|
8
|
11
|
15
|
13
|
6
|
14
|
9
|
9
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Boehringer Ingelheim International GmbH | 4493 |
6 |
| Board of Regents, The University of Texas System | 6117 |
6 |
| XENIOPRO GmbH | 16 |
6 |
| Autifony Therapeutics Limited | 51 |
5 |
| Pharmakea, Inc. | 37 |
5 |
| Purdue Pharma L.P. | 480 |
4 |
| University of Kansas | 922 |
4 |
| Centre National de La Recherche Scientifique | 11026 |
3 |
| Bayer AG | 3499 |
3 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 3247 |
3 |
| Italfarmaco SpA | 157 |
3 |
| Universite de Montpellier | 1041 |
3 |
| Glaxo Group Limited | 4360 |
2 |
| Bristol-myers Squibb Company | 4751 |
2 |
| General Electric Company | 13910 |
2 |
| BASF SE | 21308 |
2 |
| Bayer Pharma AG | 1009 |
2 |
| The General Hospital Corporation | 4871 |
2 |
| President and Fellows of Harvard College | 6092 |
2 |
| Takeda Pharmaceutical Company Limited | 2710 |
2 |
| Other owners | 109 |